Triple
T5932680
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | ICH S9 Nonclinical Evaluation for Anticancer Pharmaceuticals |
E131972
|
entity |
| Predicate | relatedTo |
P37
|
FINISHED |
| Object |
ICH S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals
ICH S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals is an international guideline that outlines the nonclinical safety testing requirements for biotechnological products such as therapeutic proteins and monoclonal antibodies to support their clinical development and marketing authorization.
|
E555163
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69c0085b75e88190a632f9691f9da48b |
elicitation | completed |
| NER | batch_69c0389df18c81909027a9db7596f0c1 |
ner | completed |
| NED1 | batch_69c0c064d2a4819096085668182cfde1 |
ned_source_triple | completed |
| NED2 | batch_69c0c1f6fe60819080a00976740b6a9c |
ned_description | completed |
| NEDg | batch_69c0c109b3288190928dc4539a2872c2 |
nedg | completed |
Created at: March 22, 2026, 4 p.m.